Aldoxorubicin Shows Promise in Advanced Soft-Tissue Sarcoma
In this interview we discuss the phase III trial of aldoxorubicin in patients with advanced soft-tissue sarcoma, which showed improved efficacy and reduced toxicity over doxorubicin.
Breast Mass Found in 48-Year-Old Patient
A 48-year-old woman presents with a mass in her right breast, and a biopsy is obtained. What is your diagnosis?
CML Patients Approach Normal Life Expectancy With Imatinib Treatment
Treatment with imatinib results in good overall survival in patients with chronic myeloid leukemia, approaching a normal life expectancy, according to the CML-IV study.
Increased Node Dissection Improved Survival in Node-Negative Oral Cavity SCC
Higher nodal yield during definitive surgery for clinically node-negative oral cavity squamous cell carcinoma was associated with improved mortality.
Chemotherapy Decision-Making in Early Breast Cancer
This video discusses chemotherapy decision-making in early-stage breast cancer, and reviews tools such as PREDICT 2.0 and the MammaPrint 70-gene assay that can help guide treatment.
FDA Grants Priority Review for New Leukemia Option
The FDA has granted priority review status for two new indications of dasatinib (Sprycel), according to the drug’s developer.
ACA Facilitates More Cancer Clinical Trial Participation
More privately insured cancer patients seeking to participate in clinical trials received approval since the passage of the Affordable Care Act, according to a new study.
FDA Expands Indication for Scalp Cooling Device to Reduce Hair Loss
The FDA has expanded the indication for a scalp cooling device that reduces hair loss during chemotherapy.
PD-L1 Testing in Lung Cancer
This video reviews the use of PD-L1 testing in selecting patients for frontline lung cancer treatment with pembrolizumab and examines which patients might not be appropriate for immunotherapy.
Drug for Relapsed, Refractory ALL Increased Hepatotoxicity
Treatment of adult relapsed or refractory acute lymphoblastic leukemia with inotuzumab ozogamicin was associated with increased hepatotoxicity, especially after follow-up hematopoietic stem cell transplantation.
By clicking Accept, you agree to become a member of the UBM Medica Community.